All Stories

  1. Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies

    Article • Cancers, August 2019, MDPI AG

    Jens Hahne

  2. Is there a correlation between clinic-pathological features, MSI, PD-L1 and survival outcomes in resected gastric cancer? Looking for optimal biomarkers.

    Article • Journal of Clinical Oncology, May 2019, American Society of Clinical Oncology (ASCO)

    Jens Hahne

  3. Circulating-free DNA analysis from long-term surviving metastatic colorectal cancer patients undergoing surgery for resectable disease.

    Article • Journal of Clinical Oncology, May 2019, American Society of Clinical Oncology (ASCO)

    Jens Hahne

  4. Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data

    Article • Therapeutic Advances in Medical Oncology, January 2019, SAGE Publications

    Jens Hahne

  5. Biliary tract cancer: current challenges and future prospects

    Article • Cancer Management and Research, December 2018, Dove Medical Press

    Jens Hahne

  6. Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors

    Article • Frontiers in Oncology, June 2018, Frontiers

    Jens Hahne

  7. PO-346 Defining microrna mediated regulation of metabolic pathways involved in colon cancer progression (BST1-microrna interactions)

    Article • June 2018, BMJ

    Jens Hahne

  8. Biomarkers for Monitoring Response to Therapies and Detection of Acquired Resistance in Advanced Gastrointestinal Cancers

    Article • December 2017, Bentham Science Publishers

    Jens Hahne

  9. Clinical development of mTor inhibitors for renal cancer

    Article • Expert Opinion on Investigational Drugs, October 2017, Taylor & Francis

    Jens Hahne

  10. Clinical outcome and molecular characterization of brain metastases from esophageal and gastric cancer: a systematic review

    Article • Medical Oncology, March 2017, Springer Science + Business Media

    Jens Hahne

  11. New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim

    Article • Therapeutics and Clinical Risk Management, June 2016, Dove Medical Press

    Jens Hahne

  12. Analysing Molecular Mechanism Related to Therapy- Resistance in In-vitro Models of Ovarian Cancer

    Article • March 2016, IntechOpen

    Jens Hahne

  13. Platinum-resistance and AKT Over-expression in Ovarian Cancer

    Article • International Journal of Gynecology & Clinical Practices, April 2015, Graphy Publications

    Jens Hahne

  14. pAKT überexprimierende Ovarialkarzinomzellen entwischen den Angriffen des Immunsystems

    Article • Geburtshilfe und Frauenheilkunde, June 2013, Thieme Publishing Group

    Jens Hahne

  15. AEZS-131- ein hochselektiver ERK-Inhibitor: Charakterisierung und präklinische Testung im tripelnegativen Mammakarzinom (TNBC)

    Article • Geburtshilfe und Frauenheilkunde, July 2012, Thieme Publishing Group

    Jens Hahne

  16. Herunterregulation von AKT reduziert die Platinresistenz beim Ovarialkarzinom in vitro

    Article • Geburtshilfe und Frauenheilkunde, July 2012, Thieme Publishing Group

    Jens Hahne

  17. P3-18-06: AEZS-131 – A Highly Selective ERK-Inhibitor: Characterization and Preclinical Testing in Triple Negative Breast Cancer (TNBC).

    Article • December 2011, American Association for Cancer Research (AACR)

    Jens Hahne

  18. P1-01-06: Mechanisms of Tumor Immune Escape in Triplenegative Breast Cancers (TNBC) with and without Mutated BRCA 1.

    Article • December 2011, American Association for Cancer Research (AACR)

    Jens Hahne

  19. The potential of proteasome inhibitors in cancer therapy

    Article • Expert Opinion on Investigational Drugs, May 2008, Informa Healthcare

    Jens Hahne

  20. Influence of preoperative core biopsies on uPA/PAI-1 expression in breast cancer tissue

    Article • Virchows Archiv, January 2008, Springer Science + Business Media

    Jens Hahne

  21. Tumor-Stroma Interactions of Metastatic Prostate Cancer Cell Lines

    Article • January 2007, Springer Science + Business Media

    Jens Hahne

  22. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts

    Article • International Journal of Molecular Medicine, November 2006, Spandidos Publications

    Jens Hahne

  23. Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion and anchorage-independent growth

    Article • Oncogene, June 2005, Springer Science + Business Media

    Jens Hahne

  24. Laser-assisted microdissection, techniques and applications in pathology (Review)

    Article • International Journal of Molecular Medicine, May 2005, Spandidos Publications

    Jens Hahne

  25. Novel tempeh (fermented soyabean) isoflavones inhibit in vivo angiogenesis in the chicken chorioallantoic membrane assay

    Article • British Journal Of Nutrition, March 2005, Cambridge University Press

    Jens Hahne

  26. Influence of histochemical stains on quantitative gene expression analysis after laser-assisted microdissection

    Article • International Journal of Molecular Medicine, April 2003, Spandidos Publications

    Jens Hahne